Loading...
XSHE300562
Market cap359mUSD
Jan 10, Last price  
12.16CNY
1D
-1.38%
1Q
-1.30%
Jan 2017
-57.96%
IPO
57.16%
Name

Guangdong Transtek Medical Electronics Co Ltd

Chart & Performance

D1W1MN
XSHE:300562 chart
P/E
76.63
P/S
2.98
EPS
0.16
Div Yield, %
0.08%
Shrs. gr., 5y
3.05%
Rev. gr., 5y
2.67%
Revenues
884m
-16.98%
233,075,873323,499,850380,847,702455,710,161629,005,528770,644,439866,590,294775,103,192883,668,2271,336,748,0721,821,072,4591,065,096,604884,256,692
Net income
34m
22,257,25828,664,41035,168,35945,339,97650,188,81980,520,70817,840,69724,015,87031,064,11570,161,7498,868,815034,367,303
CFO
74m
-12.41%
18,453,20018,660,90037,061,58954,250,46935,967,83478,177,014085,156,18074,957,79877,989,587084,650,66074,141,927
Dividend
Sep 04, 20240.13 CNY/sh
Earnings
Apr 16, 2025

Profile

Guangdong Transtek Medical Electronics Co., Ltd designs, manufactures, and sells medically approved products, connected healthcare devices, and smart wearables in China. The company offers remote patient monitoring devices, blood pressure monitors, electronic scales, multifunctional wearable, and wireless hearable devices. Guangdong Transtek Medical Electronics Co., Ltd was founded in 2002 and is based in Zhongshan, China.
URL
https://www.lifesense.com/
IPO date
Nov 16, 2016
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
884,257
-16.98%
1,065,097
-41.51%
Cost of revenue
793,488
1,035,505
Unusual Expense (Income)
NOPBT
90,769
29,591
NOPBT Margin
10.27%
2.78%
Operating Taxes
1,914
Tax Rate
2.11%
NOPAT
88,855
29,591
Net income
34,367
 
Dividends
(2,147)
(2,147)
Dividend yield
0.09%
0.09%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
128,172
138,795
Long-term debt
13,609
10,885
Deferred revenue
11,194
10,114
Other long-term liabilities
4,293
Net debt
(710,583)
(617,559)
Cash flow
Cash from operating activities
74,142
84,651
CAPEX
(12,893)
Cash from investing activities
18,362
12,539
Cash from financing activities
(11,400)
107,376
FCF
108,424
81,312
Balance
Cash
677,674
654,853
Long term investments
174,689
112,386
Excess cash
808,151
713,984
Stockholders' equity
434,763
510,698
Invested Capital
735,560
643,491
ROIC
12.89%
4.88%
ROCE
7.59%
2.50%
EV
Common stock shares outstanding
214,701
214,701
Price
11.41
0.44%
11.36
-31.03%
Market cap
2,449,741
0.44%
2,439,005
-30.89%
EV
1,722,707
1,821,447
EBITDA
119,674
60,160
EV/EBITDA
14.39
30.28
Interest
4,797
2,417
Interest/NOPBT
5.28%
8.17%